MK
Mahendra Kumar
About Mahendra Kumar
Data last updated:
Mahendra Kumar has 21 years in corporate governance. Holds Designated Partner and Director roles. Currently with 2 companies, including Medimak Pharma Llp and Makers Pharma Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Makers Pharma Private Limited at ₹72.25 Cr (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Makers Pharma Private Limited U51397TN2005PTC055683 | Director | 16 Mar 2005 | 2005 | ₹72.25 Cr (FY 2022) | Active |
| Medimak Pharma Llp AAN-4058 | Designated Partner | 05 Oct 2018 | 2018 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mahendra Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mahendra Kumar
Mahendra Kumar has 21 years in corporate governance. Holds Designated Partner and Director roles. Currently with 2 companies, including Medimak Pharma Llp and Makers Pharma Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Makers Pharma Private Limited at ₹72.25 Cr (FY 2022).
Mahendra Kumar is associated with 2 companies as Designated Partner and Director, including Makers Pharma Private Limited (₹72.25 Cr), Medimak Pharma Llp.
Mahendra Kumar has expertise in General Business.
Mahendra Kumar has 21 years in corporate governance.
By reported revenue, the largest current company of Mahendra Kumar is Makers Pharma Private Limited, with revenue of ₹72.25 Cr (FY 2022).
Mahendra Kumar currently holds positions at 2 companies: Makers Pharma Private Limited (₹72.25 Cr), Medimak Pharma Llp.